Rs 0.451.431 Protocol Of Cartagena On January 29, 2000, On The Prevention Of Biotechnological Risks Relating To The Convention On Biological Diversity (With Annexes)

Original Language Title: RS 0.451.431 Protocole de Cartagena du 29 janvier 2000 sur la prévention des risques biotechnologiques relatif à la Convention sur la diversité biologique (avec annexes)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
0.451.431 original text Cartagena Protocol on the prevention of biotechnological risks relating to the Convention on biological diversity concluded in Montreal on 29 January 2000, approved by the Federal Assembly on 4 March 2002, Instrument of ratification deposited by the Switzerland on March 26, 2003, entered into force for the Switzerland on 11 September 2003 (State on February 3, 2015) the Parties to this Protocol being Parties to the Convention of 5 June 1992 on the biological diversity hereinafter referred to as "the Convention", recalling the by. 3 and 4 of art. 19, art. 8g and art. 17 of the Convention, recalling also decision II/5 of 17 November 1995 of the Conference of the Parties to the Convention requesting the development of a Protocol on the prevention of biotechnological risks that would focus specifically on the transboundary movement of living organisms modified resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity , and which envisage, in particular, a prior informed agreement appropriate procedure, reaffirming the precautionary approach enshrined in principle 15 of the Rio Declaration on environment and development, aware that modern biotechnology is growing rapidly and that the public is increasingly concerned about the adverse effects it could have on biological diversity including the risk that it could include human health, recognizing that modern biotechnology has great potential for the well-being of humans provided that it is developed and used in conditions of security for the environment and human health, conscious of the crucial importance of the centres of origin and centres of genetic diversity for humanity taking into account the fact that many countries, including developing countries, have limited resources to cope with the nature and importance of the known and potential risks posed by living modified organisms, believing that the agreements on trade and the environment should support each other with a view to the emergence of a sustainable development, stressing that this Protocol will not be interpreted as implying a change in the rights and obligations of one party under other agreements International, considering that it is understood that this preamble is not intended to subordinate the Protocol to other international agreements, have agreed to the following: art. 1 objectives according to the precautionary approach enshrined in principle 15 of the Rio Declaration on environment and development, the objective of this Protocol is to contribute to ensuring an adequate level of protection for the transfer, handling and use without danger of living organisms modified resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity also taking into account risks to human health, focusing specifically on transboundary movements.

Art. 2 General provisions 1. Each Party shall take the legal, administrative and other measures necessary and appropriate to carry out its obligations under the Protocol.
2. the Parties shall ensure that the development, handling, transport, use, transfer and release of any living organism modified themselves so as to prevent or reduce the risks to biological diversity, taking into account also the risks for human health.
3. nothing in this Protocol shall affect in any way whatsoever, to the sovereignty of States over their territorial waters such as established in international law, or sovereign rights or jurisdiction they exercise over their exclusive economic zones and on their continental shelf under international law, nor to the exercise, by ships and aircraft of all States rights and freedoms of navigation under international law, enshrined in the relevant international instruments.
4. nothing in this Protocol shall be interpreted as restricting the right of a party to take stronger measures for the conservation and sustainable use of biological diversity than those laid down by the Protocol, provided that they are compatible with the objective and the provisions of the Protocol and in agreement with the other obligations imposed on this part by international law.
5. the Parties are encouraged to consider, appropriately, expertise, existing instruments and the work undertaken by the relevant international bodies regarding the risk to human health.

Art. 3 definitions for the purposes of the Protocol: a. "Conference of the Parties" means the Conference of the Parties to the Convention; (b) "Contained use" means any operation in a device, a facility, or any other structure physics, involving living modified organisms which are regulated by specific measures that effectively limit contact with the outside environment , and the impact on the environment; c. 'Export' means all cross-border intentional movement from a party and destined for another part d. 'Exporter' means any person moral or physical, under the jurisdiction of the exporting Party, that takes provisions for a living modified organism to be exported; e. 'Import' means all cross-border intentional movement to destination part and from another party; f. "Importer" means any legal or natural person , under the jurisdiction of the party of import, who arranges for that a living modified organism to be imported; g. "It living modified organism" means any living organism with a combination of new genetic material obtained through the use of modern biotechnology; h. "Living organism" means any biological entity capable of transferring or replicating genetic material, including sterile organisms viruses and the viroids; i. "Modern biotechnology" means: a. the application of technology in vitro nucleic acids, including the recombination of deoxyribonucleic acid (DNA) and the direct introduction of nucleic acid into cells or organelles, b. the cell bodies merge did not belong to the same taxonomic family, that overcome natural physiological reproductive or recombination barriers and that are not techniques used for the breeding and selection of classic type.
j. 'Regional economic integration organization' means any organization constituted by sovereign States of a given region, to which its Member States have transferred their competence for questions under the Protocol and which has been duly authorized, in accordance with its internal procedures, to sign, ratify, accept or approve the Protocol, or join; k. "Transboundary movement" means any movement of a living organism modified from a party and destination of another party , this close only for the purposes of art. 17 and 24, "transboundary movement" extends to movement between Parties and not party.

Art. 4 scope this Protocol applies to the transboundary movement, transit, handling and use of any living modified organism that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health.

Art. 5 pharmaceuticals notwithstanding art. 4 and without prejudice to the right of the Parties to submit any living organism modified to a risk assessment before taking a decision on its importing, the present Protocol does not apply to transboundary movements of LMOs that are pharmaceuticals for human under other agreements or relevant international organizations.

Art. 6 transit and use in confined environment 1. Notwithstanding art. 4, and without prejudice of the right of a party of transit to regulate the transport of living organisms modified its territory and notify the clearing-house mechanism for the prevention of biosafety of any decision she has made, by virtue of the by. 3 of art. 2, for the transit on its territory of a specific modified living organism, the provisions of this Protocol agree prior informed procedure shall not apply to living organisms modified in transit.
2. Notwithstanding art. 4 and without prejudice to the right of any party to submit a modified living organism whatsoever to a risk assessment before making a decision on import and to set standards for the uses confined within the limits of its jurisdiction, the provisions of this Protocol relating to the procedure prior informed agreement apply not to the transboundary movement of LMOs intended for use in the workplace which confined are carried out in accordance with the standards of the importing party.


Art. 7 application of the agreed procedure prior informed consent 1. Subject to the art. 5 and 6, the prior agreement procedure knowingly provided for in arts. 8, 9, 10 and 12 shall apply prior to the first intentional transboundary movement of LMOs that are to be intentionally introduced into the environment of the importing party.
2. the intentional introduction into the environment referred to the by. 1 above does not concern the LMOs intended to be used directly for the food or feed, or for processing.
3. art. 11 shall apply prior to the first transboundary movement of LMOs intended to be used directly for the food or feed or for processing.
4. the procedure agree prior informed consent applies to modified organisms intentional transboundary movements which, in a decision of the Conference Parties serving as meeting of the Parties to the Protocol, are defined as little likely to have adverse effects on the conservation and sustainable use of biological diversity, also taking into account risks to human health.

Art. 8 notification 1. The exporting party address, or require the exporter to ensure notification, in writing, to the competent national authority of the party of import prior to the intentional transboundary movement of a living modified organism intended to the by. 1 of art. 7. the notification contains at a minimum the information specified in Annex I. 2. The exporting Party shall there is legal liability for the accuracy of the information provided by the exporter.

Art. 9 acknowledgement of receipt of notification 1. The importing party address in writing to the author of the notification, within ninety days, an acknowledgement of the notification.
2. the acknowledgement will indicate: a. date of receipt of the notification; (b) if the notification contains at first glance the information referred to in art. 8; c. whether to proceed in accordance with the national regulatory framework of the party of import or according to the procedure laid down in art. 10 3. The domestic regulatory framework referred to in the by. 2, al. c, above must conform to the Protocol.
4. the fact, for the importing party, of not to acknowledge receipt of a notification, does not mean that she consents to the intentional transboundary movement.

Art. 10 decision procedure 1. The decisions taken by the importing party conform to art. 15 2. The importing party must, within the time prescribed in art. 9, indicate in writing to the notifier if the intentional transboundary movement may take place: a. only when the importing party has given consent in writing; forgotten the source. at the end of a period of at least 90 days without further consent in writing.

3. in the two hundred and seventy days of the date of receipt of the notification, the importing party communicates in writing, to the notifier and the clearing-house mechanism for the prevention of biosafety, the decision referred to the by. 2, al. a, above: a. authorizing the import, with or without conditions, and showing how the decision will apply to subsequent imports of the same living organism modified; (b) prohibiting the import; (c) requesting additional relevant information in accordance with its national regulations or Annex I; the number of days between the time where the importing party request for additional relevant information and that where it gets is not into account in the computation of time available to it to answer; (d) informing the notifier that the period specified in this paragraph is extended for a defined period.

4. except in the case of an unconditional consent, the decisions referred to the by. 3 above must indicate the reasons that have motivated them.
5. the fact that the importing party does not communicate its decision within two hundred and seventy days of the date of receipt of the notification does not mean that she consents to the intentional transboundary movement.
6. the lack of scientific certainty due to insufficient relevant scientific knowledge and information regarding the extent of possible adverse effects of a living organism modified on the conservation and sustainable use of biodiversity in the importing party, taking into account risks to human health, does not this part as it should be a decision on the import of the living organism modified in question as shown in the by. 3 above, to avoid or minimize such potential adverse effects.
7. the Conference of the Parties serving as the meeting of the Parties to the Protocol decide, at its first meeting, procedures and appropriate mechanisms to help the importing Parties to take a decision.

Art. 11 procedure for living organisms modified intended to be used directly for the food or feed, or for processing 1. Any party that makes a final decision regarding the use on the national territory, including putting on the market of an LMO that may be the subject of a transboundary movement and which is intended to be used directly for human or animal food or to be transformed, must, within fifteen days following, inform the other Parties, through the clearing-house mechanism for the prevention of biotechnological risks. This information should contain at least the information required in annex II. The part provides in writing a copy of this information to national correspondents of the Parties who were informed in advance the Secretariat because they have no access to the clearing-house mechanism for the prevention of biotechnological risks. This provision does not apply to decisions on the field trial.
2. any party which takes a decision in accordance with the by. 1 above ensures that legal provisions guarantee the accuracy of the information provided by the applicant.
3 any party may request additional information from the authority referred to in para. b of annex II.
4. any party may take, as part of its national regulations, a decision on the import of a living modified organism intended to be used directly for human or animal food or to be made, provided that this decision is in line with the objective of the present Protocol.
5. each party puts at the disposal of the clearing-house mechanism for the prevention of biotechnological risks a copy of all the laws, regulations and guidelines applicable to the import of LMOs intended to be used directly for human or animal food or be processed, if available.
6. all developing countries or countries with economies in transition party to this Protocol may, in the absence of the domestic regulatory framework referred to the by. 4 above, exercise of its domestic jurisdiction, declare, through the clearing-house mechanism for the prevention of biotechnological risks, that its decision prior to the first import of a LMO intended to be used directly for the food or feed or processing, on which information was provided in the application of the per. 1 above will be taken: a. at the end of a risk assessment undertaken in accordance with annex III; ETB. within a predictable timeframe, not exceeding two hundred and seventy days.

7. the fact that a party does not communicate its decision according to the by. 6 above does not mean that consent to import or that she refuses to import the modified living organism considered intended to be used directly for human or animal food or to be transformed, unless she has specified him also.
8. the lack of scientific certainty due to insufficient information and relevant scientific knowledge regarding the extent of possible adverse effects of a living organism modified on the conservation and sustainable use of biodiversity in the importing party, taking into account risks to human health, does not this part as it should be a decision on the import of this living organism modified if it is intended to be used directly as feed or feed or to be transformed, to avoid or minimize such potential adverse effects.
9. any party may make known its needs for financial and technical assistance and capacity development, regarding LMOs intended to be used directly for the food or feed or for processing. The Parties shall cooperate to meet these needs, in accordance with the art. 22 and 28 of the present Protocol.

Art. 12 review of decisions


1. a party may at any time, in the light of new scientific information on potential adverse effects on the conservation and sustainable use of biological diversity, given also the risks for human health, reconsider and change a decision regarding an intentional transboundary movement. In this case, within a period of thirty days, it shall inform the authors of previous notifications of movements of the LMO in question, as well as the clearing-house mechanism for the prevention of biotechnological risks, indicating the reasons for its decision.
2. an exporting Party or the author of a notification may request an importing party to reconsider the decision she has taken on, under art. 10, where the party of export or the notifier considers: a. that there is a change in circumstances likely to affect the results of the risk assessment who founded decision; forgotten the source. that additional technical or scientific information are available.

3. the party of import in writing meets this demand within 90 days, indicating the reasons for its decision.
4. the party of import may, at its discretion, require an assessment of the risk for subsequent imports.

Art. 13 simplified procedure 1. An importing party may, provided that adequate measures are applied to ensure the cross-border movement of intentional without danger of living organisms modified, in accordance with the objective of the Protocol, specify in advance to the clearing-house mechanism for the prevention of biotechnological risks: a. cases where an intentional transboundary movement that is the destination can take place at the same time where the movement is notified; b. imports of LMOs that are exempted from the advance informed agreement procedure of cause.

The notifications referred to in para. a above may apply to subsequent similar movements to the same party.
2. the information regarding an intentional transboundary movement that is to be included in the notification referred to the by. 1, al. a, above are those listed in annex I.

Art. 14 agreements and bilateral, regional and multilateral arrangements 1. The Parties may conclude agreements and bilateral, regional and multilateral arrangements for cross-border movements intentional of organisms modified, if they conform to the purpose of the Protocol and provided that such agreements and arrangements do not result in a degree of protection than that provided for in the Protocol.
2. the Parties inform each other, through the clearing-house mechanism for the prevention of biotechnological risks of any agreement or arrangement bilateral, regional or multilateral, that they have entered into before or after the date of entry into force of the Protocol.
3. the provisions of the Protocol have no effect on intentional transboundary movements that take place under one of these agreements or arrangements between the Parties to this agreement or arrangement.
4. any party may decide that its national regulations apply to certain specific imports intended for him and shall notify its decision to the clearing-house mechanism for the prevention of biotechnological risks.

Art. 15 1 risk assessment. The risk assessments undertaken under the present Protocol are according to scientific methods proven in accordance with annex III and taking into account the evaluation methods recognized risks. These risk assessments are based at least on the information provided in accordance with art. 8 and on other available scientific evidence to determine and evaluate the potential adverse effects organisms changed on the conservation and sustainable use of biological diversity, taking into account also the risks for human health.
2. the importing party shall ensure that a risk assessment be conducted to take a decision on the title of the art. 10. it may require that the exporter proceeds to the risk assessment.
3. the cost of the risk assessment is supported by the notifier if the party of import so requires.

Art. 16 1 risk management. Taking into account art. 8, al. g, of the Convention, the Parties shall establish and apply mechanisms, measures and strategies to regulate, manage and control the risks defined by the provisions of the Protocol relating to the assessment of risks associated with the use, handling and the movement across borders of LMOs.
2. measures based on the risk assessment are imposed to the extent necessary to prevent adverse effects of the organism on the conservation and sustainable use of biological diversity, including risks to human health, in the territory of the importing party changed.
3 each Party shall take appropriate measures to prevent cross-border movement of unintentional of LMOs, including measures requiring a risk assessment before the first release of a living modified organism.
4. without prejudice of the by. 2 above, each party ensures that any living organism modified, imported or developed locally, has been subjected to a period of observation appropriate corresponding to its life cycle or at his time of training before it can be used as expected.
5. the Parties cooperate in view: a. to identify living organisms modified characters of modified organisms that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health; (b) to take appropriate measures to deal with these modified organisms or specific traits.

Art. 17 unintentional transboundary movements and emergency measures 1. Each Party shall take appropriate measures to notify the States actually affected or capable of being, to the Clearinghouse for prevention of biosafety and, if necessary, to the relevant international organizations, all incident which it has knowledge within its jurisdiction and resulting release involving or causing a cross-border no intentional movement of a living modified organism likely to have adverse effects on the conservation and sustainable use of biological diversity taking into account also the risks for human health in these States. The notification is given as soon as the party becomes aware of this situation.
2. each Party shall communicate to the clearing-house mechanism for the prevention of biotechnological risks, at the latest at the date of entry into force of this Protocol with respect to itself, the coordinates of the person entitled to receive notifications given under this section.
3. any notification given by virtue of the by. 1 above should include the following: a. all relevant available information on the estimated quantities and characteristics and relevant characters of organisms modified; (b) information on the circumstances and date of release, as well as on the use of the body living modified in the party of origin; c. any available information on the potential adverse effects on the conservation and sustainable use of biological diversity including risks to human health, as well as all available information about possible risk management measures; (d) any other relevant information; e. the coordinates to contact for further information.

4. to minimize any adverse impact important on the conservation and sustainable use of biological diversity, also taking into account risks to human health, each party, under the jurisdiction of which is the release of the living modified organism referred to the by. 1 above immediately consult the affected States or capable of being, to enable them to determine appropriate responses and to take the necessary measures, including emergency measures.

Art. 18 handling, transport, packaging and identification 1. In order to avoid adverse effects on the conservation and sustainable use of biological diversity, also taking into account the risks to human health, each Party shall take the necessary measures to require that LMOs that are subject to intentional transboundary movement within this Protocol are handled, packaged and transported under conditions of safety, taking into account the rules and relevant international standards.
2. each Party shall take measures to require that documentation accompanying:

a. the LMOs intended to be used directly for human and animal feed, or for processing, clearly indicates that they "may contain" living modified organisms and they are not intended to be intentionally introduced into the environment, and shows the coordinates to contact for further information. The Conference of the Parties serving as the meeting of the Parties to the Protocol a decision detailing the modalities of this obligation, in particular how to specify the identity of these organizations as well as any special identification, at the latest within two years following the entry into force of the Protocol; b. the LMOs intended for use in confined clearly indicates it as LMOs , by specifying the safety rules to be observed for the handling, storage, transport and use of these organizations, and shows the coordinates to contact for further information, including the name and address of the person and the institution to which LMOs are shipped; c. LMOs destined to be introduced intentionally into the environment of the importing party , as well as any other modified living organism referred to in the Protocol, makes clear it as LMOs, specifies their identity and their traits and characteristics relevant, as well as any rule of security for the handling, storage, transport and use of these organizations, and shows the details of the person to contact for further information, as well as If applicable, the name and address of the importer and the exporter; and contains a statement certifying that the movement is consistent with the requirements of the Protocol applicable to the exporter.

3. the Conference of the Parties serving as the meeting of the Parties to the Protocol determines whether it is necessary to develop standards identification, handling, packaging and transport, and sets the terms of this development, by consulting other competent international organizations in the area.

Art. 19 competent national authorities and national focal points 1. Each Party shall designate a national correspondent responsible for in his name the liaison with the Secretariat. Each Party shall designate also one or more competent national authorities responsible to perform administrative functions that call the Protocol and authorized to act on its behalf in the performance of these duties. A party may entrust the functions of corresponding to a single entity national and national authority.
2. each Party shall to the Secretariat, at the latest on the date of entry into force of the Protocol for concerned, the names and addresses of its corresponding national and the authority or the competent national authorities. When a party designates more than one competent national authority, it indicates to the Secretariat, with its notification to this effect, what are the respective areas of responsibility of these authorities. If so, it would be at least clarified what is the competent authority for each type of modified living organism. Each Party shall immediately notify any change in the designation of its corresponding national or the name, address, or his responsibilities or its competent national authorities to the Secretariat.
3. the Secretariat immediately brings to the attention of the Parties the notifications received by virtue of the by. 2 above and shall also make this information available through the clearing-house mechanism for the prevention of biotechnological risks.

Art. 20 information sharing and Exchange Centre for the prevention of biotechnological risks 1. A clearinghouse for prevention of biosafety is created as part of the planned Clearinghouse to the by. 3 of art. 18 of the Convention, to: a. facilitate exchange of scientific, technical, environmental and legal information, as well as data of experience, related to LMOs; b. help the Parties to implement the Protocol, taking into account the specific needs of developing countries, particularly the least developed among them and small island States developing and countries with economies in transition , as well as countries that are centres of origin and centres of genetic diversity.

2. the clearing-house mechanism for the prevention of biotechnological risks is a way to make available information for the purposes identified in the by. 1 above. It allows to access information relevant to the application of the Protocol provided by the Parties. It also allows access to other international mechanisms for exchanging information on the prevention of biosafety, if possible.
3. without prejudice to the protection of confidential information, each Party shall communicate to the clearing-house mechanism for the prevention of biotechnological risks any information that it is required to provide the title of the Protocol, and: a. all the laws, regulations and national guidelines for the application of the Protocol, as well as the information required by the Parties agree prior informed procedure; b. any agreement or bilateral arrangement regional or multilateral; c. a summary of risk assessments or environmental studies on modified living organisms carried out pursuant to its regulations and carried out in accordance with art. 15, including, if necessary, relevant information regarding products derived, namely material transformed from LMOs that contains new combinations detectable of replicable genetic material obtained through the use of modern biotechnology; (d) its final decisions regarding the importation or release of living organisms modified; e. reports submitted pursuant to art. 33, including reports on the application of the prior agreement procedure informed.

4. the terms of operation of the clearing-house mechanism for the prevention of biotechnological risks, including its activity reports are reviewed and adopted by the Conference of the Parties serving as the meeting of the Parties to the Protocol at its first meeting and are subject to further reviews.

Art. 21 confidential information 1. The importing party allow the notifier to identify, among the information provided in the application procedures provided for by the Protocol or required by the party of import prior to approval proceedings knowingly of the Protocol, those must be considered as confidential. In such cases, a justification is provided on request.
2. the importing party shall consult the notifier when it decides that information considered by it as confidential does not have the conditions required to be treated as such and, before disclosing the information, she informed him of his decision, stating his reasons on request and leaving the possibility of consultations and an internal review of the decision.
3. each Party shall protect confidential information received under the Protocol, including the confidential information received under the procedure agreed prior informed of the Protocol. Each Party shall have procedures to protect this information and protects the confidentiality of such information in a manner that is as favourable as that which she uses for confidential information relating to LMOs to national origin.
4. the importing party does not use this information for commercial purposes, except with the written consent of the author of the notification.
5. If the notifier withdraws or has withdrawn it, the importing party respects the confidentiality of all commercial or industrial, information including research and development information, as well as those whose privacy is being a disagreement between the party and the notifier.
6. without prejudice of the by. 5 above, the information below are not required for confidential: a. the name and address of the author of the notification; (b) a general description of the organization or of LMOs; c. a summary of the risk assessment of impact on the conservation and sustainable use of biological diversity, taking into account also risks to human health; (d) the methods and plans for emergency response.

Art. 22 capacity-building


1. the Parties cooperate to the development and strengthening of human resources and institutional capacities in the field of the prevention of biosafety, including biotechnology insofar as it relates to the prevention of biosafety, with a view to the effective implementation of the Protocol in the developing countries Parties, in particular in the least developed countries and small island developing States , as well as Parties with economies in transition, including through global, regional, subregional and national organizations and institutions and, if it is necessary, promoting the participation of the private sector.
2. for the purposes of the by. 1 above, regarding cooperation, the needs of the countries in development parts, in particular those of the least developed countries and of small island developing States, financial resources, access to technology and know-how, and of transfer of technology and know-how in accordance with the relevant provisions of the Convention, are fully taken into account in the creation of capacities for the prevention of biotechnological risks. Cooperation in capacity-building includes, subject to differences between situations, resources and needs of each party: the scientific and technical training to rational use and without danger of biotechnology and the use of assessments of risk and biosafety management techniques, as well as the strengthening of the technical and institutional capacities in biosafety prevention. The needs of Parties with economies in transition are also fully taken into account in the creation of capacities for the prevention of biotechnological risks.

Art. 23 awareness and participation of the public 1. The Parties: a. encourage and facilitate awareness, education and participation of the public concerning the transfer, handling and use without danger of living organisms modified for the conservation and sustainable use of biological diversity, also taking into account risks to human health. The Parties, in order to do this, cooperate, as it should be, with other States and international bodies; (b) strive to ensure that awareness and education of the public include access to information on living organisms modified, within the meaning of the Protocol, which can be imported.

2. the Parties, in accordance with their laws and regulations, consult the public when making decisions on LMOs and make available to the public after these decisions, while respecting the confidential nature of the information, in accordance with art. 21 3. Each party seeks to inform the public about the means of access to the clearing-house mechanism for the prevention of biotechnological risks.

Art. 24 Parties 1. The transboundary movement of living organisms modified between Parties and not party must be compatible with the objective of the Protocol. The Parties may conclude agreements and bilateral, regional or multilateral arrangements with parties about these cross-border movements.
2. the Parties encourage the parties to adhere to the Protocol and to communicate to the clearing-house mechanism for the prevention of biotechnological risks of existing information on living modified organisms released in their territory, or subject to movements destined to or from areas under their national jurisdiction.

Art. 25 illegal transboundary movements 1. Each Party shall adopt national measures to prevent and repress, if appropriate, the transboundary movement of living organisms modified contrary to the measures it has taken to implement the present Protocol. Such movements shall be deemed illicit cross-border movement.
2. in the case of illicit cross-border movement, the affected Party may request the party of origin to eliminate the LMOs concerned, at his own expense repatriating them or destroying them, as appropriate.
3. each party puts at the disposal of the clearing-house mechanism for the prevention of illicit information related to cases of transboundary movement biosafety concerning.

Art. 26 socio-economic considerations 1. The Parties, when taking a decision on import under this Protocol or under the national measures they have taken to implement the Protocol, may take into account, in accordance with their international obligations, of the socio-economic implications of the impact of living modified organisms on the conservation and sustainable use of biological diversity, relative to the value of biological diversity to indigenous and local communities in particular.
2. the Parties are encouraged to cooperate to research and the exchange of information on the socio-economic impact of LMOs, particularly for indigenous and local communities.

Art. 27 liability and redress the Conference of the Parties, serving as the meeting of the Parties to this Protocol, committed, at its first meeting, a process to develop rules and procedures international liability and compensation for damage resulting from transboundary movements of living modified organisms, analysing and taking duly into account the ongoing work in international law on these matters , and endeavours to complete this process within four years.

Art. 28 mechanisms of funding and financial resources 1. When they examine the issue of financial resources for the implementation of the Protocol, the Parties shall consider the provisions of art. 20 of the Convention.
2. the mechanism of financing established by art. 21 of the Convention is, through the institutional structure which is responsible for the operation, the funding mechanism for the Protocol.
3. with regard to capacity-building referred to in art. 22 of the Protocol, the Conference of the Parties serving as the meeting of the Parties to the Protocol, takes into account, when it provides guidelines for the targeted funding mechanism to the by. 2 above, for consideration by the Conference of the Parties, the need for financial resources to the developing country Parties, in particular least developed countries and small island States developing.
4. in the context of the by. 1 above, the Parties shall also take into account the needs of developing countries Parties, in particular those of the least developed countries and small island developing States, as well as those of the Parties with economies in transition, when they strive to identify and meet their needs in capacity-building for the purposes of the application of the Protocol.
5. the guidelines to the funding mechanism for the Convention in relevant decisions of the COP, including those agreed before the adoption of the Protocol, shall apply, mutatis mutandis, to the provisions of this article.
6. the developed country Parties may also provide financial and technological resources for the application of the provisions of the Protocol, in the context of bilateral, regional and multilateral arrangements which the developing Parties and Parties with economies in transition will be able to use.

Art. 29 conference of the Parties serving as the meeting of the Parties to the Protocol 1. The Conference of the Parties serves as the meeting of the Parties to the Protocol.
2. the Parties to the Convention that are not Parties to the Protocol may participate as an observer in the work of any meeting of the Conference of the Parties serving as the meeting of the Parties to the Protocol. When the Conference of the Parties serves as the meeting of the Parties to the Protocol, decisions that are made under the Protocol are only by the Parties to the Protocol.
3. when the Conference of the Parties serves as the meeting of the Parties to the Protocol, any member of the Bureau of the Conference of the Parties representing a party to the Convention which is not yet a party to the Protocol is replaced by a new Member who is elected by the Parties to the Protocol among them.
4. the Conference of the Parties serving as the meeting of the Parties to the Protocol following the application of the Protocol and take, within its mandate, the decisions necessary to promote the effective application. She performs the functions assigned by the Protocol and:

a. recommendations on any matter concerning the application of the Protocol; b. establish them subsidiary bodies considered necessary to implement the Protocol; c. appealed and using, as appropriate, services, cooperation and information provided by international organizations and intergovernmental and non-governmental bodies competent; d. determines the presentation and the frequency of the transmission of the information to be provided pursuant to art. 33 of the Protocol and consider such information as well as reports submitted by its subsidiary bodies; (e) consider and adopt, as required, amendments to the Protocol and its annexes, as well as any new annex to the Protocol, considered necessary for its application; ETF. performs any other function that may require the application of the Protocol.

5. the rules of procedure of the Conference of the Parties and the financial rules of the Convention shall apply mutatis mutandis to the Protocol, unless otherwise decided by the Conference of the Parties serving as the meeting of the Parties to the Protocol by consensus.
6. the first meeting of the Conference of the Parties to the Convention serving as the meeting of the Parties to the Protocol is convened by the Secretariat at the same time as the first meeting of the Conference of the Parties, which will take place after the date of entry into force of the Protocol. Thereafter, ordinary meetings of the Conference of the Parties serving as meeting of the Parties to the Protocol will take place as part of regular meetings of the Conference of the Parties, unless the Conference of the Parties serving as the meeting of the Parties to the Protocol decides otherwise.
7. extraordinary meetings of the Conference of the Parties serving as the meeting of the Parties to the Protocol may occur at any time, if deemed necessary, the Conference of the Parties serving as the meeting of the Parties to the Protocol or at the written request of a party, provided that this is supported by one third of the Parties within six months after its communication to the Parties by the Secretariat at least.
8. the United Nations, its specialized agencies and the Agency International Atomic Energy, as well as any member of such organizations or any observer with such organizations, which is not a party to the Convention, may be represented as an observer at the meetings of the Conference of the Parties serving as the meeting of the Parties to the Protocol. Any body or institution, national or international, governmental or non governmental, competent in the areas covered by this Protocol and having informed the Secretariat of its wish to be represented as an observer at a meeting of the Conference of the Parties serving as the meeting of the Parties to the Protocol, may be admitted as such unless one third of the Parties present object. The admission and participation of observers is governed by the rules of procedure referred to the by. 5 above, unless otherwise provided in this section.

Art. 30 subsidiary bodies 1. Any subsidiary body established by, or in, the agreement may, on the decision of the Conference of the Parties serving as the meeting of the Parties to this Protocol, to perform functions in respect of the Protocol, in which case the meeting of the Parties specifies the functions carried out by this body.
2. the Parties to the Convention that are not Parties to this Protocol may participate as an observer in any meeting of a subsidiary body of the Protocol. When a subsidiary body of the Convention as a subsidiary body of the Protocol, decisions under the Protocol are taken only by the Parties to the Protocol.
3. when a subsidiary body of the Convention exercises its functions as a subsidiary body of the Protocol, any member of the Bureau of that subsidiary body representing a party to the Convention that is not yet party to the Protocol is replaced by a new Member who is elected by the Parties to the Protocol among them.

Art. 31 secretariat 1. The Secretariat established under art. 24 of the Convention served as the Secretariat of this Protocol.
2. the by. 1 of art. 24 of the Convention relating to the functions of the Secretariat shall apply mutatis mutandis to this Protocol.
3. so they are distinct, the costs of secretariat services for this Protocol are supported by the Parties to the Protocol. At its first meeting, the Conference of the Parties serving as the meeting of the Parties to the Protocol takes the necessary financial provisions.

Art. 32 relationship with the Convention except otherwise provided in this Protocol, the provisions of the Convention relating to its Protocols shall apply to this instrument.

Art. 33 monitoring and reporting each party ensures compliance with obligations that are his under this Protocol and, at intervals regular decided by the Conference of the Parties serving as the meeting of the Parties to the Protocol, shall report to the Conference of the Parties serving as the meeting of the Parties to the Protocol on measures that it has taken to implement the provisions.

Art. 34 compliance the Conference of the Parties serving as the meeting of the Parties to the Protocol review and approve, at its first meeting, the procedures and institutional mechanisms for cooperation to encourage respect for the provisions of the Protocol and to address cases of non-compliance. These procedures and mechanisms have provisions to offer advice or assistance, as appropriate. They are separate from and without prejudice to the procedure and mechanisms for settlement of disputes established under art. 27 of the Convention.

Art. 35 assessment and review the Conference of the Parties serving as the meeting of the Parties to the Protocol shall, five years after the entry into force of the Protocol, and then at least every five years, give an evaluation of its effectiveness, including an assessment of its procedures and annexes.

Art. 36 signature this Protocol is open for signature of States and the regional economic integration organizations to the United Nations Office at Nairobi from 15 to 26 May 2000, and at United Nations Headquarters in New York from 5 June 2000 to 4 June 2001.

Art. 37 entry into force 1. This Protocol comes into force on the ninetieth day following the date of deposit of the fiftieth instrument of ratification, acceptance, approval or accession by States or regional economic integration organizations that are Parties to the Convention.
2. the present Protocol comes into force for a State or a regional organization of economic integration which ratifies, accepts, approves or adhere after its entry into force in accordance with the by. 1 above, or the ninetieth day after the date of filing, by that State or that organization of economic integration, its instrument of ratification, acceptance, approval or accession, or at the time when the Convention comes into force for that State or that regional economic integration organization, the later date is later.
3. for the purposes of by. 1 and 2 above, any instrument deposited by a regional economic integration organization is considered as coming alongside the instruments already deposited by Member States of the organization.

Art. 38 reservations no reservations may be made to this Protocol.

Art. 39 denunciation 1. At the expiration of a period of two years from the date of entry into force of this Protocol with respect to a party, that party may denounce the Protocol by written notification to the depositary.
2. the denunciation shall take effect on the expiry of a period of one year from the date of its receipt by the depositary, or on any later date that will be specified in the notification.

Art. 40 texts being authentic the original of this Protocol, of which the English, Arabic, Chinese, English, french and Russian texts are equally authentic, shall be deposited with the Secretary-General of the Organization of the United Nations.
In faith whereof, the undersigned, to this authorized, have signed this Protocol.
Done at Montreal, on 29 January, two thousand.
(Follow signatures)

Annex I information required in notifications to introduce in accordance with art. 8, 10 and 13


a. name, address and contact information of the exportateur.b. name, address and contact information of the importateur.c. name and identity of the living modified organism and its ranking based on the degree of biological security in the State of export, is it existe.d. Date or dates of the transboundary movement if they are connues.e. Common name and taxonomy, point of collection or acquisition, and characteristics of the receiving agency or agencies parents relevant to the prevention of risks biotechnologiques.f. Centres of origin and centres of genetic diversity, if known, the receiver body and/or parents organizations and the description of the habitats where the organisms may persist or proliferer.g. Common names and taxonomy, point of collection or acquisition, and characteristics of the organization or donor agencies relevant to the prevention of risks biotechnologiques.h. Description of the nucleic acid or introduced modification, the technique used and the characteristics of the organism which changed to resultent.i. Intended use of the living organism modified or products derived, namely transformed material originating with the modified living organism, containing detectable new combinations of replicable genetic material obtained through the use of biotechnology moderne.j. Quantity or volume of organisms changed to transferer.k. Report pre-existing on the risk assessment which is in line with annex III.the. Proposed methods for the handling, storage, transport and safe use, including packaging, labelling, documentation, disposal methods and procedures to be followed in case of emergency, the echeant.m case. Situation of the living organism modified under the regulations in the State of export (for example, if it is prohibited in the exporting State, if there are other restrictions, or if its general release has been authorized); If the LMO is prohibited in the exporting State, the reason of this interdiction.n. Result and purpose of any notification by the exporter to other States regarding the living organism modified to transferer.o. Statement that the above information is accurate.

State on 3 February 2015 annex II information to be provided for all LMO intended to be used directly for the food or feed, or be transformed in accordance with art. 11A. The name and contact information of the person seeking an authorisation for use in the national.b territory. The name and contact details of the authority responsible for the decision.c. The name and identity of the organism alive modifie.d. A description of the genetic modification, the technique used, and the characteristics of the organism which changed to resultent.e. Any unique identification of the body alive modifie.f. Taxonomy, common name, point of collection or acquisition, and characteristics of receiving agency or agencies parents relevant for the prevention of risk biotechnologiques.g. The centres of origin and centres of genetic diversity, if known, the receiver body and/or parents organizations and a description of the habitats where the organisms may persist or proliferer.h. Taxonomy, common name, point of collection and acquisition, and the relevant agency or donor agencies characteristics for the prevention of risk biotechnologiques.i. The uses allowed agency alive modifie.j. A report on the risk assessment that is in accordance with annex III.k. The methods proposed for the handling, storage, transport and safe use, including packaging, labelling, documentation, disposal methods and procedures to be followed in case of emergency, as appropriate.

February 3, 2015 State annex III objective 1 risk assessment. For the purposes of the present Protocol, the assessment risk has to determine and evaluate the potential adverse effects organisms changed on the conservation and sustainable use of biodiversity in the likely potential receiving environment, taking into account also risks to human health.
Use of the 2 risk assessments. The risk assessment is used by the competent authorities for a decision informed regarding LMOs.
General principles 3. The risk assessment should be carried out according to scientific methods and transparency and can take into account guidelines and technical advice of relevant international organizations.
4 do not necessarily infer from the lack of knowledge or scientific consensus the seriousness of a risk, the absence of risk, or an acceptable risk.
5. the risks associated with living modified organisms or products derived, namely the material transformed from LMOs that contains detectable new combinations of replicable genetic material obtained through the use of modern biotechnology, should be considered regarding the risks posed by the receiving organizations or parents unmodified in the likely potential receiving environment.
6. the risk assessment should be made on a case by case basis. The nature and the degree of accuracy of the required information may vary depending on the case, based on the modified organism concerned, its intended use and the likely potential receiving environment.
Methods 7. The risk assessment may require further information on specific issues, which can be identified and requested during the assessment; on the other hand, information on other issues may not be relevant in some cases.
8. to achieve its goal, the risk assessment will include, as appropriate, the following steps: a. identify all new genotypic and phenotypic characteristics associated with the modified organism that may have adverse effects on biological diversity in the likely potential receiving environment, and also involve risks to human health; (b) the assessment of the likelihood of these adverse effects occur taking into account the level and kind of exposure of the likely potential receiving environment agency living modifiec. the evaluation of the consequences should these adverse effects if they arise; d. the estimation of the overall risk presented by the Organization living modified on the basis of the assessment of the probability of the occurrence of the identified adverse effects and their consequences; (e) a recommendation indicating whether the risks are acceptable or manageable, including, if necessary, the definition of risk management strategies; ETF. When there are uncertainties as to the seriousness of the risk, you can request further information on specific issues of concern, or implement appropriate management strategies risk and/or control the organism living modified in the receiving environment.

Points to consider 9. According to the case, evaluating risk takes into account the technical data and relevant scientists on: a. the receiving agency or agencies parents: biological characteristics of agency or agencies parents, including clarification of the taxonomy, the common name, origin, centres of origin and centres of genetic diversity, when they are known, and a description of the habitat where organizations may persist or proliferate; b. the agency or donor agencies : Taxonomy and common name, source and relevant biological characteristics of donor agencies; c. the vector: the characteristics of the vector, including identity, if necessary, its source or origin, and range of guests; d. the insert or inserts and/or characteristics of modification: the genetic characteristics of the inserted nucleic acid and the function that it determines , and/or the characteristics of the modification introduced; e. the Organization living modified: identity of the living modified, and differences between the biological characteristics of the living modified organism and those of the receiving agency or agencies parents; f. the detection and the identification of the body living modified: methods of detection and identification proposed and their peculiarity, significance and reliability, g. information on the intended use : Information on the intended use of the living organism modified, including any new use or any use differing from that of the receiving organization or parent; ETH. the receiving environment: Information on the location and features geographical, climatic and ecological of the likely potential receiving environment, including information on biological diversity and the centres of origin that are there.

State on 3 February 2015 scope on 3 February 2015 States parties Ratification, accession (A) entry into force Afghanistan 20 February 2013 has May 21, 2013 South Africa August 14, 2003 A November 12, 2003 Albania February 8, 2005 may 9, 2005 Algeria August 5, 2004 November 3, 2004 Germany November 20, 2003 February 18, 2004 Angola


February 27, 2009 may 28, 2009 Antigua - and - Barbuda September 10, 2003 December 9, 2003 Saudi Arabia August 9, 2007 7 November 2007 Armenia 30 April 2004 was 29 July 2004 Austria 27 August 2002 11 September 2003 1 April 2005 Azerbaijan has 30 June 2005 Bahamas January 15, 2004 April 14, 2004 Bahrain 7 February 2012 was May 7, 2012 Bangladesh 5 February 2004 May 5, 2004 Barbados 6 September 2002 A September 11, 2003 Belarus 26 August 2002 At September 11, 2003 Belgium April 15, 2004 July 14, 2004 12 February 2004 Belize's May 12, 2004 Benin 2 March 2005 May 31, 2005 Bhutan August 26, 2002 A September 11, 2003 Bolivia April 22, 2002 11 September 2003 Bosnia and Herzegovina 1 October 2009 December 30, 2009 Botswana 11 June 2002 11 September 2003 Brazil November 24, 2003 was 22 February 2004 Bulgaria 13 October 2000 September 11, 2003 Burkina Faso 4 August 2003 2 November

2003 Burundi October 2, 2008 to December 31, 2008 Cambodia September 17, 2003 has 16 December 2003 Cameroon February 20, 2003 September 11, 2003 Cape Town - Green 1 November 2005 was January 30, 2006 China June 8, 2005 September 6, 2005 Hong Kong may 9, 2011 may 9, 2011 Cyprus 5 December 2003 has March 4, 2004 Colombia may 20, 2003 September 11, 2003 Comoros 25 March 2009 A June 23, 2009 Congo (Brazzaville) July 13, 2006 October 11, 2006 Congo (Kinshasa)

March 23, 2005 June 21, 2005 Korea (North) 29 July 2003 October 27, 2003 (South) Korea October 3, 2007 January 1, 2008 Costa Rica February 6, 2007 may 7, 2007 Croatia 29 August 2002 11 September 2003 Cuba 17 September 2002 11 September 2003 Denmark August 27, 2002 11 September 2003 Djibouti 8 April 2002 has 11 September 2003 Dominique 13 July 2004 has October 11, 2004 Egypt 23 December 2003 22 March 2004 El El Salvador September 26, 2003

December 25, 2003 12 September 2014 United Arab Emirates has 11 December 2014 Ecuador January 30, 2003 September 11, 2003 10 March 2005 Eritrea has Spain June 8, 2005 * January 16, 2002 11 September 2003 Estonia 24 March 2004 June 22, 2004 Ethiopia October 9, 2003 January 7, 2004 Fiji June 5, 2001 September 11, 2003 Finland July 9, 2004 October 7, 2004 France April 7, 2003 September 11, 2003 Gabon 2 May 2007 to July 31, 2007 Gambia 9 June 2004 September 7, 2004 Georgia 4 November 2008 at February 2, 2009 Ghana 30 May 2003 September 11, 2003 Greece may 21, 2004 August 19, 2004 Granada February 5, 2004 May 5, 2004 Guatemala 28 October 2004 has 26 January 2005 Guinea December 11, 2007 10 March 2008 Guinea - Bissau may 19, 2010 to August 17, 2010 Guyana 18 March 2008 was June 16, 2008 Honduras November 18, 2008 February 16, 2009 Hungary 13 January 2004 April 12, 2004

Islands Marshall 27 January 2003 A September 11, 2003 India January 17, 2003 September 11, 2003 Indonesia December 3, 2004 March 3, 2005 Iraq March 3, 2014 was June 1, 2014 Iran 20 November 2003 18 February 2004 Ireland November 14, 2003 February 12, 2004 Italy March 24, 2004 June 22, 2004 Jamaica September 25, 2012 December 24, 2012 Japan 21 November 2003 A February 19, 2004 Jordan 11 November 2003 9 February 2004 Kazakhstan September 8, 2008 A 7 December 2008 Kenya 24 January 2002 11 September 2003 Kyrgyzstan 5 October 2005 to 3 January 2006 Kiribati April 20, 2004 July 19, 2004 Laos August 3, 2004 1 November 2004 Lesotho 20 September 2001 has 11 September 2003 Latvia February 13, 2004 May 13, 2004 Lebanon 6 February 2013 has 7 may 2013 Liberia February 15, 2002 11 September 2003 Libya 14 June 2005 was September 12, 2005 Lithuania 7 November 2003 5 February 2004 Luxembourg

August 28, 2002 11 September 2003 Macedonia June 14, 2005 September 12, 2005 Madagascar November 24, 2003 February 22, 2004 Malaysia September 3, 2003 December 2, 2003 Malawi 27 February 2009 27 May 2009 Maldives 3 September 2002 A September 11, 2003 Mali August 28, 2002 11 September 2003 Malta 5 January 2007 was 5 April 2007 Morocco April 25, 2011 July 24, 2011 Maurice April 11, 2002 11 September 2003 Mauritania 22 July 2005 has 20 October 2005

Mexico August 27, 2002 11 September 2003 Moldova 4 March 2003 September 11, 2003 Mongolia 22 July 2003 was October 20, 2003 Montenegro 23 October 2006 S 3 June 2006 Mozambique October 21, 2002 11 September 2003 Myanmar 13 February 2008 may 13, 2008 Namibia 10 February 2005 may 11, 2005 Nauru 12 November 2001 has 11 September 2003 Nicaragua August 28, 2002 11 September 2003 Niger September 30, 2004 December 29, 2004 Nigeria 15 July 2003 October 13, 2003

Niue 8 July 2002 A September 11, 2003 Norway 10 May 2001 11 September 2003 New Zealand 24 February 2005 may 25, 2005 Oman April 11, 2003 A September 11, 2003 Uganda 30 November 2001 11 September 2003 Pakistan March 2, 2009 may 31, 2009 Palau June 13, 2003 September 11, 2003 Palestine January 2, 2015 has 2 April 2015 Panama may 1, 2002 11 September 2003 Papua New Guinea 14 October 2005 was January 12, 2006 Paraguay March 10 2004 8 June

2004 Netherlands January 8, 2002 11 September 2003 Peru April 14, 2004 July 13, 2004 Philippines October 5, 2006 January 3, 2007 Poland December 10, 2003 March 9, 2004 Portugal September 30, 2004 December 29, 2004 Qatar 14 March 2007 A 12 June 2007 Republic Central African November 18, 2008 February 16, 2009 Dominican Republic 20 June 2006 has September 18, 2006 Czech Republic October 8, 2001 September 11, 2003 Romania June 30, 2003 September 28, 2003 United Kingdom November 19, 2003

February 17, 2004 Gibraltar may 30, 2014 May 30, 2014 Rwanda July 22, 2004 October 20, 2004 St. - Lucia 16 June 2005 has 14 September 2005 Saint - Kitts - and - Nevis May 23, 2001's September 11, 2003 Saint - Vincent - and - the Grenadines 27 August 2003 A November 25, 2003 Salomon, Islands July 28, 2004 has October 26, 2004 Samoa 30 May 2002 11 September 2003 South Africa October 8, 2003 January 6, 2004 Serbia 8 February 2006 has 9 May 2006 Seychelles may 13, 2004 August 11, 2004

Slovakia November 24, 2003 February 22, 2004 Slovenia November 20, 2002 September 11, 2003 Somalia 26 July 2010 A October 24, 2010 June 13, 2005 Sudan has 11 September 2005 Sri Lanka April 28, 2004 26 July 2004 Sweden August 8, 2002 11 September 2003 Switzerland March 26, 2002 11 September 2003 Suriname 27 March 2008 has 25 June 2008 Swaziland 13 January 2006 has April 13, 2006 Syria April 1, 2004 to June 30, 2004 Tajikistan February 12, 2004 May 12, 2004 Tanzania 24 April 2003 A September 11, 2003 Chad November 1, 2006 January 30, 2007 November 10, 2005 Thailand has 8 February 2006 Togo 2 July 2004 September 30, 2004 Tonga September 18, 2003 A December 17, 2003 Trinidad and Tobago 5 October 2000 has 11 September 2003 Tunisia 22 January 2003 September 11, 2003 Turkmenistan August 21, 2008 A November 19, 2008 Turkey October 24, 2003 January 24, 2004 Ukraine December 6, 2002 A September 11, 2003

European Union August 27, 2002 11 September 2003 Uruguay November 2, 2011 January 31, 2012 Venezuela 13 May 2002 11 September 2003 Viet Nam 21 January 2004 was 20 April 2004 Yemen December 1, 2005 to March 1, 2006 Zambia 27 April 2004 A July 25, 2004 Zimbabwe 25 February 2005 may 26, 2005 * reservations and declarations. Reservations and declarations are not published to the RO. Texts in french and English can be found at the address of the Internet site of the United Nations: http://treaties.un.org or obtained in the Direction of public international law (FDFA), the international treaties Section, 3003 Bern.




The Protocol does not apply to Tokelau.

2004 579 RO; FF 2001 3884 RO 2004 577 RS 0.451.43 RO 2004 606 3713, 2005-2335, 2007 1401, 2008 4121, 2010 17, 2011 4887, 2013 1485, 2015 591, 2006-791-4451. A version of the update scope is published on the web site of the FDFA (www.dfae.admin.ch/traites).

State on February 3, 2015

Related Laws